Results 151 to 160 of about 9,912 (208)

Correction: Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats. [PDF]

Sci Rep
Sedik AA, El-Nasr NMEA, Khalil WKB, El-Mosallamy AEMK.   +3 more
europepmc   +1 more source

Comparison of renal function of the patients receiving linagliptin or vildagliptin in uncontrolled type 2 diabetes mellitus: An observational study in the backdrop of the COVID-19 pandemic.

Indian J Pharmacol
Chaudhuri S, Biswas S, Mukhopadhyay S, Dasgupta S.   +3 more
europepmc   +1 more source

Efficacy and Safety of Once-Weekly Trelagliptin As Compared to Twice-Daily Vildagliptin in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Phase 3, Non-inferiority Clinical Trial. [PDF]

Cureus
Dewan B, Shinde S, Roy S.
europepmc   +1 more source

Comparative Efficacy, Safety, and Cost-Utility of DPP-4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real-World Clinical and Economic Outcomes. [PDF]

J Diabetes Res
Jimoh AO, Hudu SA, Sabir AA, Adamu AA, Bello N, Tahir A, Abubakar N.   +6 more
europepmc   +1 more source

SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis. [PDF]

J Transl Med
Rostami-Afshari B, Elremaly W, Franco A, Elbakry M, Akoume MY, Boufaied I, Moezzi A, Leveau C, Rompré P, Godbout C, Mella O, Fluge Ø, Moreau A.   +12 more
europepmc   +1 more source

Vildagliptin and its Association with Bullous Pemphigoid.

Ann Afr Med
Meah A, Reddy KS, Rajeshwari KA.
europepmc   +1 more source

Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats. [PDF]

World J Gastroenterol
Oyama M, Kaji K, Nishimura N, Hanatani J, Nakatani T, Nishimura N, Shibamoto A, Asada S, Tsuji Y, Kitagawa K, Sato S, Namisaki T, Yoshiji H.   +12 more
europepmc   +1 more source

Identification, Isolation and Structural Elucidation of New Inner Salt Impurity in Vildagliptin and Metformin Tablet by Using Supercritical Fluid Chromatography, NMR, HRMS. [PDF]

J Sep Sci
Meganathan SK, Sahoo BK, Reddy YR, Rajani K, Reddy PR.   +4 more
europepmc   +1 more source

Correction: SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis. [PDF]

J Transl Med
Rostami-Afshari B, Elremaly W, Franco A, Elbakry M, Akoume MY, Boufaied I, Moezzi A, Leveau C, Rompré P, Godbout C, Mella O, Fluge Ø, Moreau A.   +12 more
europepmc   +1 more source

Efficacy of Initial Basal-Supported Oral Therapy with Sitagliptin in Untreated Type 2 Diabetes [PDF]

core   +1 more source